Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Eur J Haematol ; 113(1): 72-81, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-38553844

RESUMEN

OBJECTIVES: Bacterial infections are common and a major cause of morbidity and mortality in multiple myeloma (MM). We have investigated the function of polymorphonuclear leukocyte (PMN), the immune system's first line of defense against bacteria, in peripheral blood (PB) and bone marrow (BM) samples from patients with newly diagnosed MM (NDMM), smoldering MM (SMM), monoclonal gammopathy of undetermined significance (MGUS) and healthy controls. METHODS: Phagocytosis and oxidative burst in PMN cells from patients and healthy donors were investigated using PhagoTest and PhagoBurst assay. RESULTS: PMN from NDMM, SMM, and MGUS patients had reduced phagocytosis and oxidative burst ability compared with healthy controls. The dysfunction was most prominent in BM samples from MM, SMM, and MGUS patients. Importantly the reduced phagocytosis in MM patients was restored in patients on lenalidomide therapy. Consistently the ability of Escherichia coli stimulated oxidative burst in BM was reduced for the MM, SMM, and MGUS cohort in contrast to the healthy controls and the patients on lenalidomide treatment. CONCLUSION: Our results show that MM patients have neutrophil dysfunction that could contribute to susceptibility for bacterial infections and that lenalidomide therapy was associated with restored PMN function.


Asunto(s)
Lenalidomida , Mieloma Múltiple , Neutrófilos , Fagocitosis , Estallido Respiratorio , Humanos , Lenalidomida/uso terapéutico , Neutrófilos/inmunología , Neutrófilos/metabolismo , Mieloma Múltiple/tratamiento farmacológico , Mieloma Múltiple/diagnóstico , Fagocitosis/efectos de los fármacos , Estallido Respiratorio/efectos de los fármacos , Masculino , Femenino , Persona de Mediana Edad , Anciano , Estudios de Casos y Controles , Gammopatía Monoclonal de Relevancia Indeterminada/diagnóstico , Gammopatía Monoclonal de Relevancia Indeterminada/tratamiento farmacológico , Adulto , Anciano de 80 o más Años , Talidomida/análogos & derivados , Talidomida/uso terapéutico , Talidomida/farmacología , Médula Ósea/patología , Médula Ósea/metabolismo
2.
J Immunol Res ; 2022: 8077281, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36438199

RESUMEN

Normal density granulocytes (NDGs) can suppress T-cell responses in a similar way as myeloid-derived suppressor cells (MDSCs). In this study, we tested the hypothesis that NDGs from healthy donors preferentially inhibit T helper 1 (Th1) cells and investigated the myeloid-derived suppressive effect in different T-cell populations. We found that NDG-induced suppression of T-cell proliferation was contact dependent, mediated by integrin CD11b, and dependent on NDG-production of reactive oxygen species (ROS). The suppression was rapid and occurred within the first few hours of coculture. The suppression did not influence the CD8+/CD4+ ratio indicating an equal sensitivity in these populations. We further analyzed the CD4+ T helper subsets and found that NDGs induced a loss of Th1 surface marker, CD183, that was unrelated to ligand-binding to CD183. In addition, we analyzed the Th1, Th2, and Th17 cytokine production and found that all cytokine groups were suppressed when T-cells were incubated with NDGs. We therefore concluded that NDGs do not preferentially suppress Th1-cells. Instead, NDGs generally suppress Th cells and cytotoxic T-cells but specifically downregulate the Th1 marker CD183.


Asunto(s)
Citocinas , Activación de Linfocitos , Regulación hacia Abajo , Proliferación Celular , Granulocitos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA